Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation

NCT03255265 is registered in ClinicalTrials.gov with Fuzhou General Hospital as lead sponsor.

NCT NCT03255265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03255265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation
Lead sponsor
Fuzhou General Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2017
Completion date
December 31, 2021
Enrollment
950 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

organ transplant rejection